newsfilter
← Latest News
PR Newswire·

NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...